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Cerebral palsy (CP) is a complex multifactorial disorder, affecting approximately 
2.5–3/1000 live term births, and up to 22/1000 prematurely born babies. CP results from 
injury to the developing brain incurred before, during, or after birth. The most common 
form of this condition, spastic CP, is primarily associated with injury to the cerebral cortex 
and subcortical white matter as well as the deep gray matter. The major etiological fac-
tors of spastic CP are hypoxia/ischemia (HI), occurring during the last third of pregnancy 
and around birth age. In addition, inflammation has been found to be an important factor 
contributing to brain injury, especially in term infants. Other factors, including genetics, 
are gaining importance. The classic Rice–Vannucci HI model (in which 7-day-old rat 
pups undergo unilateral ligation of the common carotid artery followed by exposure to 
8% oxygen hypoxic air) is a model of neonatal stroke that has greatly contributed to CP 
research. In this model, brain damage resembles that observed in severe CP cases. This 
model, and its numerous adaptations, allows one to finely tune the injury parameters to 
mimic, and therefore study, many of the pathophysiological processes and conditions 
observed in human patients. Investigators can recreate the HI and inflammation, which 
cause brain damage and subsequent motor and cognitive deficits. This model further 
enables the examination of potential approaches to achieve neural repair and regenera-
tion. In the present review, we compare and discuss the advantages, limitations, and the 
translational value for CP research of HI models of perinatal brain injury.
Keywords: spastic hemiplegic cerebral palsy, hypoxia–ischemia, Hi rodent model, white matter damage, perinatal 
brain injury, myelination, oligodendrocyte, periventricular leukomalacia
iNTRODUCTiON: wHAT iS CeReBRAL PALSY?
Cerebral palsy (CP) is the most common pediatric neurodevelopmental physical disability, with 
a prevalence of 2.0–3.5/1000 births (1). This condition results in a spectrum of motor and devel-
opmental disturbances leading to movement disorders, as well as cognitive impairments, speech 
and language disorders, growth problems, or pain. CP is an umbrella term for several etiologic 
conditions. Additionally, the term CP describes a range of disturbances in motor function, with 
spastic CP being the most common condition accounting for 80% of cases (2).
In this review, we will provide an overview of CP, its etiology, and its main pathophysiological 
mechanisms. Understanding the biological mechanisms of CP has been possible through the use of 
FiGURe 1 | Multiple-hit hypothesis of cerebral palsy: a combination of two or more factors is more likely to trigger and modulate lesions in the brain, 
causing CP. Adapted from Ref. (10, 15).
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various animal models, although it is beyond the scope of this 
review to describe all of them in detail. We will, therefore, focus 
on rodent hypoxic–ischemic models. Following a summary of 
the classic hypoxic–ischemic Rice–Vannucci rodent model, we 
will focus on other HI rodent models developed to mimic the 
pathophysiological events in humans and discuss the potential of 
these models in CP research.
Cerebral palsy was originally described by William Little in 
1861 (3). Since that time, the definition of CP has constantly 
evolved alongside scientific and technical progress. In 1997, 
Palisano et al. described the Gross Motor Function Classification 
System (GMFCS), which was further revised in 2007. This 
reference system provides five levels of classification based on 
self-initiated movements, including sitting, walking, and wheeled 
mobility (4, 5). In 2006, “The Definition and Classification of 
Cerebral Palsy, April 2006,” further defined CP:
Cerebral palsy describes a group of permanent 
 disorders of the development of movement and pos-
ture, causing activity limitation, that are attributed 
to non-progressive disturbances that occurred in the 
developing fetal or infant brain. The motor disorders of 
cerebral palsy are often accompanied by disturbances 
of sensation, perception, cognition, communica-
tion, and behaviour, by epilepsy, and by secondary 
 musculoskeletal problems.
The definition of CP can be approached from several angles 
indicating the complexity of the syndrome: (1) the anatomical 
site of the brain lesion; (2) the clinical symptoms and signs 
(e.g., spasticity, dyskinesia, or ataxia); (3) the topographical 
involvement of extremities (e.g., diplegia, quadriplegia, or hemi-
plegia); (4) the timing of presumed insult (e.g., prepartum, intra-
partum, or post-neonatal); and (4) classification of the degree of 
muscle tone (e.g., isotonic, hypotonic, or hypertonic) (6, 7). CP 
patients often present with mixed symptoms. For research and 
knowledge transfer purposes, a standardized and more consistent 
classification has been proposed (1, 8). However, no simple defi-
nition of CP exists; this issue is discussed further in an excellent 
review by Rosenbaum and colleagues (9).
eTiOLOGY OF CeReBRAL PALSY
The causal factors for CP are multiple and may be linked. Figure 1 
summarizes the multiple-hit hypothesis of CP pathobiology. CP 
can follow a brain abnormality that occurs pre, peri, or postna-
tally or some combination thereof. Even when the injury occurs 
at a defined time, moderating factors may also exist (10, 11). The 
risk factors for CP include: preterm birth, intra-uterine growth 
restriction, maternal/fetal infection, inflammation, perinatal 
and intrapartum difficulties (e.g., hypoxic–ischemic insult), and 
genetic predispositions (1, 12, 13). Remarkably, intrapartum 
hypoxia–ischemia (HI) is thought to account for only 14.5% of 
CP cases (14). The importance of inflammation in CP onset has 
also been recently reviewed by Van Steenwinckel and colleagues 
[Figure 2; (15)].
A recent study has shown de novo copy number varia-
tions (CNVs) in the genome are clinically relevant to CP (16). 
Furthermore, genes, such as KAK1, AP4MI, or GAD1, have been 
shown to play a role in up to 45% of CP cases (17, 18).
FiGURe 2 | Tri-phasic hypothesis of the perinatal brain damage: major action elements and processes. The acute phase occurs minutes after the insult, 
while the secondary phase happens hours after. A tertiary phase, which can last for months/years and result in developmental disturbances has also been proposed. 
The secondary phase can be skipped in some situations. Adapted from Ref. (15).
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It has been suggested that males and females may also respond 
differently to developmental brain injury. For instance, males 
born preterm (at 28 weeks of gestation in these studies) have been 
reported to be more susceptible to white matter damage (19, 20).
Developmental stage also plays a crucial role in determining 
the response to an insult. Generally, insults occurring during 
the first trimester of gestation are linked to abnormal cerebral 
development (e.g., schizencephaly). Insults in the late second and 
early third trimester typically lead to periventricular white matter 
injury (PVWMI), often associated with neuronal abnormalities 
but not necessarily neuronal loss, while insults in the late third 
trimester trigger cortical and deep gray matter lesions (21). Up 
to 24  weeks of gestation, cortical neurogenesis is defined by 
proliferation, migration, and formation of neural precursor cells 
and neurons. In the following weeks of gestation, other dynamic 
mechanisms take place: growth (axon/dendrites formation), 
differentiation (synaptogenesis, myelination), and maintenance 
(i.e., apoptosis, pruning) and/or specialization (development of 
circuitry). These mechanisms persist up to 2 years after birth (10, 
22). Therefore, any injury occurring in the immature brain will 
trigger a cascade of developmental disturbances (Figure 2).
PATHOPHYSiOLOGY
Characteristics of Brain Lesions: 
Periventricular Leukomalacia
One of the most common pathological causes of CP is perive-
ntricular leukomalacia (PVL). PVL has three forms: cystic, 
non-cystic, and diffuse. Cystic and non-cystic forms of PVL 
encompass aspects of focal necrosis and diffuse injury of the 
white matter. While cystic focal necrosis, which is macroscopic, 
turns into cysts, the microscopic non-cystic necrosis turns into 
glial scars (23, 24). A diffuse white matter injury is characterized 
by astrogliosis and microgliosis as well as hypo-myelination, due 
to lower amounts of pre-myelinating oligodendrocytes (OLs) 
(22, 24, 25). These lesions can be accompanied by hemorrhage 
in the germinal matrix, the periventricular zone, or into the 
ventricle (26–28).
There are a number of potential underlying mechanisms for 
diffuse PVL. The most studied mechanism is pre-oligodendrocyte 
(pre-OL) injury: a disruption of the OL lineage leading to serious 
impairment of axonal myelination and development caused by 
a deficit of trophic factors release (29, 30). Also, as a secondary 
event, axonal injury has been proposed as a mechanism leading to 
axonal degeneration, hypo-myelination, and decreased cortical 
and thalamic volumes. The subplate neurons, which are among 
the first neurons to appear in the cerebral cortex, play a crucial role 
in the development of the cerebral cortex and deep nuclei (wir-
ing and functional maturation), and their impairment triggers 
secondary and maturational effects. Neonatal HI causes selective 
subplate neuronal death, which is responsible for abnormal 
cortical development (31). Subplate neuronal injury subsequently 
leads to plasticity impairments (32, 33). Thalamic development 
is also affected. In fact, thalamic neuronal injury leads to white 
matter axon damage and gliosis. Finally, the dorsal telencephalic 
subventricular zone and the late GABAergic migrating neurons, 
which are crucial to the structure of the upper cortical layers, are 
prone to primary injury [see Ref. (27)].
Davatzikos et al. report that the growth of the corpus callo-
sum, which connects the left and right cerebral hemispheres and 
contains commissural myelinated fibers, is severely impaired in 
premature infants with PVL, though type of PVL is not specified 
in this work (34). This pathology preferentially occurs around 
the lateral ventricles, which are close to major cerebral arteries. 
This also affects descending corticospinal tracts (CSTs) and leads 
to neuromotor deficits, including CP (34–36). Subplate neurons 
have a fundamental role in the elaboration of connections 
between the thalamus and the cortex, as well as within the cortex 
TABLe 1 | Comparative timetable of oligodendrocyte predominating 
subtypes during development in human and rodent.
This table is an indication of the accumulated literature, which includes divergent 
publications. We do not intend to suggest that the subtypes exist only within these time 
windows. OL, oligodendrocyte; wg, weeks of gestation; wc, weeks after conception; 
ED, embryonic day; PND, PostNatal Day; FL, fetal loss; XP, extremely preterm; VP, very 
preterm; P, preterm; T, term; PsT, post-term. Adapted from Ref. (2, 45, 56, 58, 61).
Period of highest susceptibility to periventricular white matter injury .
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(37). Thus, thalamocortical, corticocortical, and corticospinal 
 synaptogenesis are impaired, leading to compromised connec-
tivity and mapping in rodents (2, 38, 39). The most prominent 
anatomical feature in the onset of spastic CP is the lesion of the 
sensorimotor cortex and its subcortical white matter (40).
It has generally been understood that there are primary and 
secondary injury events in PVL. The primary event is reported 
as being a key contributor to the pathobiology while, in the 
secondary phase, developmental disturbances involving the 
cerebral white matter and other structures: thalamus, basal gan-
glia, cerebral cortex, brainstem, and cerebellum occur (27, 41). 
Interestingly, recent studies have shown that growth impairments 
are not linked to neuronal death, but rather to dendritic arbor 
maturation alteration, spine density dendritic network decrease 
(42), and disturbance in synapse formation of the cortical neu-
rons (43).
Recently, a tertiary phase of persisting injury, lasting for 
months or years, linked to persistent inflammation and possibly 
epigenetic changes, has been identified (Figure 2). These long-
term epigenetic modifications, which have been suggested as 
potential mechanisms involved in various pathologies, include 
phosphorylation, ubiquitination and acetylation of histones, and 
methylation of DNA and RNA. This third phase not only inhibits 
regeneration and/or exacerbates brain damage, but also sensitizes 
the brain to additional injury, such as myelin deficits. Cerebral 
plasticity is also reduced, further contributing to the abnormal 
development of the brain (20).
Disruption of Oligodendrocyte Maturation
In humans, susceptibility to PVWMI peaks between 23/24 and 
32  weeks of gestation (44, 45) This vulnerability to hypoxia/
ischemia/trauma has several causes, including the higher energy 
needs of the brain to support the rapid development of white 
matter. Also, as the brain grows, the distance between blood 
vessels increases, which makes the oxygen and blood supply 
more critical (46, 47). It is now apparent that OL precursor cell 
intrinsic hypoxia-inducible factors (HIFs) signaling is a key cou-
pler of white matter angiogenesis and the onset of myelination 
postnatally (48).
Myelination impairment is linked to the disrupted OL differ-
entiation process, characterized by a deficit of myelinating mature 
OL (22, 49, 50). Back et al. showed that PVL has a developmental 
window that starts before the beginning of myelination, when late 
OL progenitors are the predominant OL type. When myelina-
tion starts in the periventricular white matter, a decline of PVL 
incidence is also observed. This indicates that the presence of late 
OL progenitors (Pre-OLs) is linked to the risk of PVL and defines 
them as a preferential target in PVL (44, 51).
Comparative timetables between human and other species for 
the various developmental stages have been proposed to facilitate 
the understanding of PVWMI onset during development. The 
differences of brain structure and development between human 
and rodents do not allow perfect comparisons. However, Table 1 
summarizes the human and rodent OL developmental stages. 
Briefly, embryonic day (ED) 17 to postnatal day (PND) 2 in 
rodents corresponds to 14–23 gestation weeks in humans. PNDs 
2–3 in rodents are similar to 23–32 weeks in humans (preterm 
infant). PNDs 7–10 in rodents are comparable to 36–40 weeks in 
humans (term infant). A rodent at PNDs 20–21 is comparable to a 
2–3 years old human (2, 45, 52–54). Contradictory opinions exist 
regarding the timing of maturation of OLs. In a review by Semple 
et  al., it was suggested that the maturation peak of Pre-OLs 
occurs at PNDs 1–3 (45), by contrast, a time window of PNDs 
2–5 has been suggested in a review by Clowry (2, 55). However, 
several reports indicate that the maturation peak occurs at PND 
2 (56–58). Moreover, Dean et al. showed that immature OLs peak 
at PND 5 in rat, while Semple et al. suggested a predominance of 
immature OLs between PNDs7 and 10 (45, 58). It is now clear that 
OL progenitors persist into adulthood, contributing to myelina-
tion processes as well as to other mechanisms, such as neuronal 
activity modulation (59, 60).
Cellular Mechanisms
Ischemia/oxygen glucose deprivation and inflammation are the 
main mechanisms that initiate PVL and they can facilitate each 
other (56, 62). Increase of pro-inflammatory cytokines has also 
been linked to PVL (63, 64). Interestingly, models of ischemic 
brain injury, such as the intra-uterine growth restriction model 
show damage that mimics CP conditions (65–67).
Other mechanisms include neurotransmitter-mediated exci-
totoxicity and oxidative stress (free-radical release), as well as 
alteration of the extracellular matrix (23, 47). Figure 3 shows the 
cellular and molecular mechanisms triggered by glutamate and 
pro-inflammatory cytokines.
Pre-OLs, more so than immature OLs, are particularly vulner-
able to HI insults. Early OL progenitors respond to white matter 
injury by a rapid and significant phase of proliferation. The pool 
of pre-OLs is, thus, dramatically increased. However, these cells 
fail to differentiate further and do not repair white matter (50, 53), 
resulting in development arrest that is likely linked to inhibitory 
factors released by reactive astrocytes, such as interleukin-1, and 
microglia (15, 49).
Oligodendrocytes express neurotransmitter receptors [e.g., 
glutamate and adenosine-triphosphate (ATP)] and respond to 
signals conveyed by axons. Under pathological conditions, they 
trigger a surge of intracellular calcium that disrupts the Ca2+ 
homeostasis to which OLs are highly sensitive (70).
FiGURe 3 | Cellular and molecular mechanisms to PvL onset: 
upstream mechanisms (cerebral hypoxia/ischemia and maternal 
infection/fetal inflammation) activate downstream mechanisms 
(glutamate excitotoxicity and free radical release) leading to cellular 
deficiencies, in particular oligodendrocyte maturation impairment 
and myelination deficit. Pre-OL, pre-oligodendrocyte; Rc, receptor; AMPA, 
α-3-amino-hydroxy-5-methyl-4-isoxazole propionic acid; KA, kainate; NMDA, 
N-methyl-D-aspartate; ROS, reactive oxygen species; RNS, reactive nitrogen 
species [adapted from Ref. (23, 47, 50, 68, 69)].
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Hypoxia–Ischemia caused by oxygen and glucose deficits 
leads to a decrease in ATP which in turn compromises the 
sodium–potassium ATP pump, crucial for membrane polar-
ity maintenance (69). Interestingly, during ischemia, anoxic 
depolarization initiates extracellular ATP release from glial 
cells (71).
Adenosine-triphosphate-mediated toxicity, through the 
ionotropic P2X and the metabotropic P2Y purino-receptors (72), 
leads to apoptosis or necrosis and is correlated with the degree of 
intracellular Ca2+ surge (73).
Depolarization induces excessive glutamate release, which 
activates the ionotropic glutamate receptors AMPA, Kainate, and 
NMDA present in OLs. In addition, activation of metabotropic 
glutamate receptors (mGluRs), strongly expressed by pre-OLs, 
leads to a calcium influx (74, 75). Interestingly, the reuptake 
function of the glutamate transporter (GluT) is disrupted in 
pathological conditions after HI and the glutamate is released 
instead of being recaptured, which further increases its extracel-
lular concentration (76).
Calcium is responsible for the activation of diverse enzymes, 
such as phospholipases, proteases, endonucleases, and neuronal 
nitric oxide synthase. The surge of intracellular calcium affects 
the mitochondria, which captures cations and subsequently pro-
duces free radicals and reactive oxygen/nitrogen species (ROS/
RNS). Oxidative stress has a profound impact on enzyme func-
tion, transcription factor expression, lipid oxidation, and DNA 
damage (47, 69).
Various other neurotransmitter receptors, such as Dopamine 
D2 and D3, GABAA, and Adenosine A receptors have been shown 
to play a role in mature OL injury after HI (75, 77, 78). Other 
mechanisms include upregulation of the expression of members 
of the kinin protein family. OLs respond to kinins via specific 
receptors that elicit a calcium influx (79).
The presence of a systemic inflammatory state sensitizes the 
brain to injury. Increased concentrations of peripheral cytokines 
are a marker of cerebral inflammation since, in a neuro-inflam-
matory context, a sustained release of cytokines alters the blood–
brain barrier. Infection can predispose the fetus to white matter 
lesions, leading to neurological impairments (15). Interestingly, 
some studies failed to show a direct causal link between chorio-
amnionitis or fetal infection and early brain development abnor-
malities in preterm infants, while neonatal infection shows higher 
risk of injury (80, 81). However, several other animal studies have 
shown a strong link between fetal infection and brain injury. For 
example, intraperitoneal injection of interleukin-1β (IL-1β) in 
newborn mice triggers systemic inflammation that modifies pro-
grams controlling brain development (82). IL-6 has been shown 
to be a key trophic factor for OL survival in vitro, while this effect 
is increased when associated with other trophic factors, such as 
neurotrophins (83). IL-6 and tumor necrosis factor α stimulate 
astrocyte proliferation and inhibit neural precursor cell prolifera-
tion in rodents. Lipopolysaccharide (LPS) has also been shown to 
cause susceptibility to hypoxic–ischemic insult in the newborn 
brain (84). Remarkably, while cytokines can be pro-inflammatory 
and act as mediators in the infection process, they also can have 
neuroprotective properties (63).
Inflammation can also trigger gliosis, which is a non-specific 
response to injury from glial cells, such as astrocytes and microglia. 
Microglia are among the first cells to react to injury and mediate 
neurotoxicity and they are strongly involved in the inflammatory 
response (85). Reactive astrocytes contribute to the glial scar 
and can subsequently inhibit axonal regrowth and myelination 
(86). Inflammation also contributes to microglia activation and 
augments their phagocytic capacity (20), leading, for example, 
to phagocytic degeneration of axons and necrotic/apoptotic cells 
(87). Microglia and reactive astrocytes also release interferon γ, 
which has a damaging effect on pre-OLs in PVL (88).
Other components, altered by the inflammation process, play 
an important role in glial scarring. For example, chondroitin 
sulfate proteoglycans (CSPGs) and immunoglobulin cell adhe-
sion molecules (IgCAMs) inhibit regeneration, and activation of 
toll-like receptors (TLRs) alters the neuroimmune response and 
OL maturation (20, 89, 90).
A recent study, however, suggested that hyperoxia (excess of 
oxygen) and/or hypoxia can alter the expression of various genes, 
independent of any oxidative stress mechanisms (24). The level 
of oxygen can regulate transcription factors, such as the HIFs, 
which are heterodimers of an oxygen-regulated α subunit and an 
oxygen-insensitive β subunit. Three HIFs have been described 
to date. In the absence of oxygen, HIF1 and 2 are deactivated 
by asparaginyl and prolyl hydroxylases, two oxygen-dependent 
enzymes. Thus, HIFs cannot form a heterodimer with the β subu-
nit and translocate to the nucleus to elicit specific DNA transcrip-
tion (91). Therefore, postnatal myelination (starting at PND7–9 
and peaking at PND15–21) is impaired if pre-OLs-encoded HIF 
function is altered by the absence of oxygen (48).
TABLe 2 | Major pathophysiological processes in CP reproduced in the 
rodent Hi model.
Pathophysiological processes Human patients 
with CP
Hi model
Structural injury
Brain injury in the ipsilateral hemisphere, 
from slight to severe, in the cortex, 
striatum, hippocampus, and corpus 
callosum. Infarctions observed in the 
cortex and hippocampus
(27, 41, 92) (93)
Focal injury (cystic and non-cystic PVL) 
and diffuse injury (astrogliosis, microgliosis, 
oligodendrocyte death) in the white 
matter, cortex, and subcortical structures. 
Hemorrhages
(10, 27, 92) (27, 93)
Cellular injury
Selective vulnerability of late 
oligodendrocyte progenitors to hypoxia–
ischemia: rodent postnatal days 2–3; 
human gestational weeks 23–32
(2, 44, 45) (2, 45, 56)
Oxidative stress: free radical release (10, 62, 94, 95) (23, 96, 97)
Glutamate-mediated excitotoxity: 
involvement of NMDA and mostly AMPA 
receptors
(68, 69, 96, 98)
Metabolic disturbances
Blood flow decrease in white matter and 
subcortical white matter structures
(99, 100) (101)
Hyperventilation, hypocapnea, metabolic 
compensation
(92) (102)
Glucose and oxygen exhaustion in the 
ipsilateral hemisphere
(103)
Retardation of anaerobic glycolytic flux, 
ATP depletion, and ultimate tissue damage
(101)
Role of inflammation
Contribution of perinatal infection to the 
evolution of the damage
(15, 104, 105) (82, 84, 106)
Genetic component
Hypoxia–ischemia has an impact on gene 
expression
N/A (24, 48)
Genetic predisposition (16–18, 107) (19)
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In summary, CP is triggered during a time of rapid brain 
development and maturation with many mechanisms at play, 
most notably an alteration of brain development. The major 
pathophysiological events occurring during CP onset in both 
rodents and humans may be seen in Table 2.
COGNiTive iMPAiRMeNTS
In addition to motor impairment, as categorized by the GMFCS, 
children with CP are more susceptible to several other health 
problems. These include orthopedic problems, epilepsy, chronic 
pain, as well as sensory and cognitive impairments. Indeed, 
children with CP often exhibit cognitive and behavioral deficits, 
including lower IQ, deficits in short-term memory, and hearing 
impairment frequently resulting in speech deficiencies and/
or delayed language development (108, 109). Moreover, visual 
perception is often affected by CP, and is considered to be a core 
disorder of the CP syndrome (110).
Very preterm or very low birth weight infants are at significant 
risk of developing cognitive impairments (111). Neonatal brain 
injury in these children leads to adverse attention and processing 
speed outcomes at the age of 7 (112). MRI has become a tool 
to assess neonatal brain injury and predict potential childhood 
outcomes (113, 114).
Animal studies have helped to characterize these cognitive 
impairments. Neuro-behavioral tests in animal models of CP 
have shown a number of cognitive impairments, including selec-
tive and long-lasting learning and memory impairments (115), 
and deficits in auditory processing (116).
Interestingly, male HI rats can learn a complex spatial 
memory task if exposed to gradual and repetitive situations, 
whereas performance is reduced if a high memory demand is 
requested at once (117). Furthermore, differing results have 
been observed according to which brain hemisphere is injured, 
supporting the notion that the neonatal right brain is more 
vulnerable to HI (118, 119). However, many human studies 
and animal bilateral injury models have failed to confirm the 
concept of brain lateralization, suggesting the need for further 
investigation in this area.
POTeNTiAL THeRAPieS
Therapeutic hypothermia is a standard of care procedure for term 
infants with moderate or severe perinatal asphyxia (120–122). 
This treatment is, however, not recommended in preterm infants 
due to potential collateral damage, such as intra-cerebral hemor-
rhage (122).
In an immature newborn, therapeutic strategies could interfere 
with the normal development of the brain making use of potential 
neuroprotective agents risky. Robertson et  al. reviewed several 
compounds, including US-Food and Drug Administration (FDA) 
approved (i.e., Tetrahydrobiopterin, Melatonin, Erythropoietin) 
and not FDA approved (i.e., Xenon, Epo-mimetics), that could 
be used to treat the newborn infant (123).
Fleiss and colleagues (20) also reviewed the treatment options 
for tertiary brain damage, including targeting long-lasting 
inflammation, modulation of microglia or lymphocytes, and cell 
therapy.
The use of stem cells as a potential regenerative approach 
seems to be a promising strategy. Functional recovery after stem 
cell transplantation has been shown in many cases, including 
in spinal cord injury models (124, 125) and in a dysmyelinated 
animal model (126). However, many aspects of cell therapies, 
such as safety, efficacy, timing, and dose, still need to be opti-
mized (127), while a combinatorial approach with, for example, 
rehabilitative strategies, use of growth factors or engineered stem 
cells, is likely to be the optimal strategy rather than any of these 
alone (128).
Clinical trials for CP encounter difficulties defining recruit-
ment criteria and recruiting participants, mainly due to the 
heterogeneous patient population or inadequate group sizes. 
Rodent models can be of great help since they allow the examina-
tion of biological mechanisms in a safe and cost-effective manner. 
They are also a useful tool for testing therapeutic strategies. For 
example, specific microRNAs have been shown to regulate T-cell 
7Rumajogee et al. Rodent HI and Cerebral Palsy
Frontiers in Neurology | www.frontiersin.org April 2016 | Volume 7 | Article 57
 function and intracellular ATP concentrations. Furthermore, 
growth factors as well as drug and cell therapies are being inves-
tigated in animal models (20, 129).
Therefore, the need for rodent models of CP is great. However, 
each adaptation of the classic hypoxic–ischemic Rice–Vannucci 
model should be proven to be clinically relevant, and used 
appropriately once validated. The following sections discuss the 
advantages, limitations, and translational value of these models.
THe CLASSiC RiCe–vANNUCCi MODeL
The Rice–Vannucci rat HI model (93) is the first and best studied 
HI neonatal model. This model allowed the study of the mecha-
nisms underlying HI-related brain damage during development 
and is one of the most productive models of perinatal brain injury 
to have been described (130).
This model, using postnatal day 7 (PND7) neonate rats, is an 
adaptation of the Levine model of HI in adult rats. It is widely 
accepted that the 7-day-old rat has brain maturity equivalent to 
that of a term/near term human fetus (131).
Briefly, this model is accomplished as follows: the common 
carotid artery is ligated unilaterally in PND7 Sprague-Dawley rat 
pups. The animals rest for 4–8 h before being exposed to hypoxic 
air (8% oxygen) for 3.5 h at 37°C. They are subsequently returned 
to their dam. In this original publication, brain damage was 
observed after 50 h in the ipsilateral hemisphere but not in the 
contralateral one (93). Others have observed damage much ear-
lier (e.g., 2 h following the insult) (132). Using these experimental 
conditions, hypoxia alone (without carotid occlusion) does not 
result in brain damage nor does carotid unilateral occlusion alone 
(without hypoxia) (133). After unilateral carotid occlusion alone, 
a regulation of the ischemic effect has been observed due to the 
presence of the circle of Willis that allows compensation in the 
blood flow between the brain hemispheres.
The injury induced in this model can be described as a spec-
trum, ranging from “moderate” to “severe.” Selective neuronal 
death or infarction can be observed, depending on the severity 
of the HI insult (93, 133, 134). The injuries affect the cerebral 
cortex, the deep gray matter (striatum of the basal ganglia and 
thalamus), the subcortical and periventricular white matter, 
and  the hippocampus in the majority of the animals (90%). It 
should be noted that only 56% of the animals have an infarction, 
suggesting a variability in the technique.
A hypoxic–ischemic insult of an inadequate level to induce 
rapid cell death and infarction can trigger some prolonged injury 
mechanisms. Glutamate excitotoxicity as well as oxidative stress 
play crucial roles in cell death following HI insult (133).
This model has been adapted many times since it was origi-
nally described. It has been confirmed to be extremely useful in 
various studies of perinatal hypoxic–ischemic brain damage. 
Since its first description in 1981, the Rice–Vannucci model has 
been widely used and adapted by scientists around the world, on 
various species.
However, studies have revealed that the model does not mimic 
the human condition optimally. Specifically, the stage of white 
matter development in PND7 rats and the type of injury produced 
are not similar to that in humans. At PND7, the majority of OLs 
in rat brains are at the immature stage of development as defined 
by O4+/O1+ immunohistochemistry (57). By contrast, human 
injury occurs when OLs are at the earlier stage of development, 
which can be distinguished by O4+/O1− staining (44). O4+/
O1− staining shows that the corresponding period in rodents is 
PND 2 (56–58). Another important consideration involves the 
type of injury the model aims to reproduce. Most cases of PVL 
resulting in CP are associated with diffuse apoptotic and relatively 
small necrotic areas in the infant brain, affecting mostly white 
matter (23, 92, 135), while the Rice–Vannucci model often results 
in severe injury with multiple infarctions involving both white 
matter and gray matter (93, 136), which accounts less than for 5% 
of PVL cases (137–139).
SUBTYPeS OF THe RODeNT Hi MODeL
In recent years, several optimizations of the rodent HI model 
have been developed to match the pathophysiological processes 
underlying brain injury and the consequences observed in 
human CP patients. Major differences in brain anatomy and the 
speed of brain development exist between humans and rodents. 
Fine-tuning of the timing and the parameters of the injury insult 
have resulted in a more accurate reproduction of the changes 
observed in humans (Table 3).
The first optimization of the HI model was done in 1996, when 
hypoxic–ischemic injury was induced in rat pups at PND1 (140). 
At PND 1, rat brain development is at a comparable stage to the 
human brain in the last trimester of gestation (149). Sheldon et al. 
showed that evolution of brain damage following HI includes 
progressive neuronal loss, white matter thinning, activation of 
microglia, and macrophages (140). Rat brains with this injury 
present with infarctions, necrotic areas, and cystic lesions similar 
to those seen in infants with severe forms of PVL (28).
As more research was undertaken using the HI model, 
concerns about strain differences were raised. In particular, 
susceptibility to the injury, mortality rates, and post-injury plas-
ticity. Studies were commenced to obtain reproducible HI rodent 
models with controllable and standardized degrees of brain 
damage. Different strains of mice were compared in a study by 
Sheldon and colleagues (141), in which the CD1 strain was found 
to be preferable as it showed maximum brain vulnerability with 
little or no mortality. 129Sv and CB57 strains were found to be 
extremely resistant to injury and displayed very high mortality, 
respectively.
One year later, in 1999, a new HI model was developed which 
employed bilateral common carotid artery occlusion (BCAO) 
in Wistar rats at PND5 with no subsequent hypoxic conditions 
(142). The authors aimed to reproduce the ischemic conditions 
that occur in the human fetus, i.e., reduction of cerebrospinal 
fluid (CSF) flow resulting in mostly white matter lesions. In the 
Rice–Vannucci model, CSF flow in subcortical white matter was 
reduced by 60% (101), and was followed by severe white and gray 
matter damage. By contrast, in the BCAO model, CSF flow in sub-
cortical white matter was reduced by 25%, which resulted in mild 
diffuse white matter damage in 64% of brains, or severe white 
matter damage with necrotic areas and cystic lesions in 36% of 
brains, while gray matter was spared. However, other researchers 
TABLe 3 | Hypoxia–ischemia (Hi) and ischemiaa rodent models developed to mimic pathophysiological processes and conditions in infants with prenatal asphyxia.
Species, 
Reference
insult Age at the 
time of injury/
duration of the 
surgery
Age at 
the time 
of result 
acquisition
Anatomical injury immune/inflammatory 
response
Functional injury Contribution/advantage  
of the model
Sprague-
Dawley 
rats (93) 
Left common 
carotid artery 
ligation, halothane 
anesthesia, 8% O2 
for 3.5 h at +36°C
P7/not exceed 
20 min
P9 From slight to severe injury found in the 
cortex, striatum, hippocampus in ipsilateral 
hemisphere, and corpus callosum in 90% 
of animals. Infarctions in 56% of animals, 
involving cortex and hippocampus
Activated microglia, 
astrocytes, fibroblast-like 
elements in the adventitia 
of arteries. Activated 
macrophages were 
identified around infarction 
zones
No neurological abnormalities 
(no circling, hemiparesis, 
convulsions), normal reflexes
Brain edema is a consequence, 
not a cause, of brain damage. 
Heightened vulnerability of the 
foci of myelinogenesis similar to 
humans. The first and the best 
studied HI model
Sprague-
Dawley 
rats (140)
Right common 
carotid artery 
ligation, halothane 
anesthesia, 6% O2 
for 3.5 h at +37°C
P1 P2–P10 Severe unilateral injury. Necrosis in the cortex, 
thinning of anterior corpus callosum
Microglia activation from 
days 2 to 6, progressive 
neuronal loss in the cortex 
and astrogliosis in the 
cortex, hippocampus, and 
corpus callosum
Not reported The first HI model to study the 
effect of earlier HI injury (at P1) 
which corresponds to prenatal 
period in humans. Evolution of 
brain damage following HI injury
C57Bl/6, 
129Sv and 
CD1 mice 
(141)
Right common 
carotid artery 
ligation, halothane 
anesthesia, 8% 
O2 for 30, 60, and 
90 min at +37°C
P7 Five days 
after the HI 
procedure
CD1 strain was the most susceptible for the 
injury, and induced the least mortality. 129Sv 
appeared to be the most resistant strain 
with high mortality. CB57 – intermediate 
vulnerability with high mortality
Not reported Not reported Comparison of HI injury effects 
on different mouse strains: CD1 
and CD1 × CB57 hybrids are 
the best mouse strains to study 
HI injury mechanisms
Wistar rats 
(142)
Bilateral common 
carotid arteries 
occlusion (cut) 
(BCAO model), 
sodium pentobarbital 
anesthesia, no 
hypoxic conditions, 
+36–37°C for 
recovery
P5 P7 Ninety-one percent of animals showed mild 
to severe white matter lesions in corpus 
callosum internal capsule, subcortical white 
matter (HE staining, gradual scoring). Cortical 
neurons were spared (APP marking)
Not reported Not reported First model of permanent 
bilateral artery ligation. 
Coagulation necrosis, cystic, 
and diffuse lesions, selectively 
in white matter
Wistar rats 
(143)
Bilateral common 
carotid artery 
temporary ligation, 
for 10 min, during 
which pups were 
kept in 8% O2
P7 Six and 
24 h after HI 
procedure
Significant depletion of oligodendrocytes 
(O4 +) in corpus callosum, at both 6 and 
24 h after injury. Astrocyte counts appeared 
normal (GFAP)
Not reported Not reported First HI model to investigate 
temporary effects of hypoxic–
ischemic conditions on cell 
survival
Long-
Evans rats 
(96)
Unilateral common 
carotid artery 
ligation, anesthesia 
with ether, hypoxia 
6% O2 for 1 h at 
+33–34°C
P7 48–96 h 
after HI
Selective subcortical white matter injury (MBP 
expression loss, ISEL-positive cells exclusively 
in the white matter). AMPA receptors were 
at maximal concentration at P7 compared 
with P4; AMPA antagonist attenuated injury 
maximally at P7, compared to P4 and P11
Not reported Not reported Model of selective white matter 
injury, which was found to be 
mediated by AMPA receptors 
at P7 
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Species, 
Reference
insult Age at the 
time of injury/
duration of the 
surgery
Age at 
the time 
of result 
acquisition
Anatomical injury immune/inflammatory 
response
Functional injury Contribution/advantage  
of the model
Sprague-
Dawley 
rats (144)
Bilateral common 
carotid arteries 
ligation, pups 
kept at +37°C for 
recovery. Isoflurane 
anesthesia. No 
subsequent hypoxic 
conditions
P1 P7 and P14 Decreased number of immature (O4+/O1+) 
and rare mature (MBP+) oligodendrocytes 
at P7
At P7, activation of 
macrophages and microglia 
(ED1, OX42)
Not reported Preferential diffuse injury of 
subcortical white matter, 
without coagulation necrosis 
and cystic lesions
Wistar rats 
(84)
Unilateral right 
carotid artery cut, 
anesthesia agent not 
mentioned, 7.7% 
O2 for 10–50 min. 
Four hours before 
HI procedure, a 
single dose of 
lipopolysaccharide 
(LPS) was given, 
0.3 mg/kg i.p.
P7 P10 LPS administration in combination with HI 
procedure induced much more severe tissue 
injury (area of infarction, astrogliosis, microglia 
presence) compared to HI alone
CD14 mRNA expression 
significantly increased both 
following LPS/HI and LPS 
alone. Toll-like-receptor 
(TLR)-4 mRNA was 
decreased in LPS/HI group
Not reported Study has established a 
model to study contribution 
of perinatal infection to the 
evolution of brain damage 
Sprague-
Dawley 
rats (56)
Left common carotid 
artery ligation, 
anesthesia method 
not mentioned, 6% 
O2 for 4 h at +37°C 
at P2 or 8% O2 for 
2.5 h at P7
P2 and P7 Twenty-four 
hours and 
1 week after 
HI injury
Following HI at P2, late OL progenitors were 
decreased (O4+/O1−), and several markers 
of cell death were increased (cytochrome 
c accumulation in cytoplasm, caspase-3 
activation, TUNEL). At P7, 92% of OLs were 
at immature stage (O4+/O1+), and were 
much less vulnerable to HI insult than late 
OLs progenitors (O4+/O1−)
Not reported Not reported Selective vulnerability of 
late OL progenitors to 
hypoxia–ischemia
Sprague-
Dawley 
rats (145)
Left common carotid 
artery coagulation, 
halothane 
anesthesia, 10 min 
of hypoxia with 6% 
O2 at +35–37°C
P3/10 min Three days 
after HI
Significant neuronal damage was found 
in cortical regions in the brain that are 
associated with sensorimotor integration 
and movement control, thalamus and basal 
ganglia, but not in hippocampus (fuchsin–
thionin staining). Apoptotic and necrotic 
cells were described (TUNEL), as well as 
astrogliosis (GFAP) in the above areas. White 
matter damage was not quantified
Not reported Not reported Consistent pattern of mild 
cortical injury seen in a surviving 
preterm human infant. White 
matter damage was not 
quantified
Sprague-
Dawley 
rats (146)
Bilateral carotid 
artery ligation, 
isoflurane 
anesthesia, HI 8% 
O2 for 10 or 15 min
P4 P21 Severe (15 min of hypoxia) brain injury: 
decreased thickness of corpus callosum at 
bregma level (LFB), and the number of mature 
oligodendrocytes (APC staining). HI of 10 min 
has not induced significant alterations
Not reported Righting reflex, wire hanging 
test, cliff avoidance test, 
and locomotor activity did 
not reveal any differences. 
Several gait parameters 
were impaired, increased 
preference of open arms in a 
plus-maze test 
Fifteen minutes of hypoxia-
induced severe damage to 
white and gray matter with 
identified necrotic cells; several 
behavioral impairments were 
found
9
R
um
ajogee et al.
R
odent H
I and C
erebral P
alsy
Frontiers in N
eurology | w
w
w
.frontiersin.org
A
pril 2016 | Volum
e 7 | A
rticle 57
(Continued)
TABLe 3 | Continued
S
p
ec
ie
s,
 
R
ef
er
en
ce
in
su
lt
A
g
e 
at
 t
he
 
ti
m
e 
o
f 
in
ju
ry
/
d
ur
at
io
n 
o
f 
th
e 
su
rg
er
y
A
g
e 
at
 
th
e 
ti
m
e 
o
f 
re
su
lt
 
ac
q
ui
si
ti
o
n
A
na
to
m
ic
al
 in
ju
ry
im
m
un
e/
in
fl
am
m
at
o
ry
 
re
sp
o
ns
e
Fu
nc
ti
o
na
l i
nj
ur
y
C
o
nt
ri
b
ut
io
n/
ad
va
nt
ag
e 
 
o
f 
th
e 
m
o
d
el
W
is
ta
r 
ra
ts
 
(1
47
)
R
ig
ht
 c
om
m
on
 
ca
ro
tid
 a
rt
er
y 
cu
t b
y 
th
er
m
oc
au
te
riz
at
io
n,
 
is
ofl
ur
an
e 
an
es
th
es
ia
, H
I 8
%
 
O
2 
fo
r 
60
 m
in
 a
t 
+3
7°
C
P
3/
5–
10
 m
in
24
–4
8 
h 
an
d 
6 
w
ee
ks
 
af
te
r 
H
I
M
ild
 m
ye
lin
 lo
ss
 (M
B
P
 s
ta
in
in
g)
 a
nd
 c
or
tic
al
 
da
m
ag
e 
w
as
 o
bs
er
ve
d 
6 
w
ee
ks
 a
fte
r 
in
ju
ry
 
in
 b
ot
h 
ge
nd
er
s.
 F
em
al
es
 o
nl
y:
 2
-im
in
ob
io
tin
 
(2
-I
B
) p
re
ve
nt
ed
 re
le
as
e 
of
 c
yt
oc
hr
om
e 
c 
fro
m
 
m
ito
ch
on
dr
ia
 (c
as
pa
se
-3
-d
ep
en
de
nt
 p
at
hw
ay
 
of
 a
po
pt
os
is
) (
24
 a
nd
 4
8 
h 
af
te
r 
H
I),
 a
nd
 b
ra
in
 
da
m
ag
e 
(6
 w
ee
ks
 a
fte
r 
H
I)
N
ot
 re
po
rt
ed
N
ot
 re
po
rt
ed
P
at
hw
ay
s 
le
ad
in
g 
to
 H
I-
in
du
ce
d 
ce
ll 
de
at
h 
ar
e 
ge
nd
er
-
de
pe
nd
en
t: 
in
 fe
m
al
es
, c
ap
as
e-
3-
m
ed
ia
te
d 
ap
op
to
si
s,
 b
ut
 n
ot
 
in
 m
al
es
C
57
B
l/6
 
m
ic
e 
(1
48
)
U
ni
la
te
ra
l l
ef
t 
ca
ro
tid
 a
rt
er
y 
lig
at
io
n,
 is
ofl
ur
an
e 
an
es
th
es
ia
, 1
0%
 O
2 
fo
r 
50
–8
0 
m
in
P
5
P
12
H
I f
or
 7
0 
m
in
 in
du
ce
d 
w
hi
te
 (M
B
P
 s
ta
in
in
g)
 
an
d 
gr
ay
 m
at
te
r 
in
ju
ry
 (M
A
P
2)
, i
nc
lu
di
ng
 
hi
pp
oc
am
pa
l a
tr
op
hy
. 5
0 
m
in
 o
f H
I i
nj
ur
ed
 
a 
sm
al
l p
er
ce
nt
ag
e 
of
 a
ni
m
al
s 
an
d 
no
 w
hi
te
 
m
at
te
r 
da
m
ag
e 
(M
B
P
 s
ta
in
in
g)
, 8
0 
m
in
-
ex
te
ns
iv
e 
in
fa
rc
tio
n 
in
 m
ul
tip
le
 a
re
as
H
I 7
0 
m
in
: p
rim
ar
ily
 T
h1
/
Th
17
-t
yp
e 
im
m
un
e 
re
sp
on
se
: u
pr
eg
ul
at
io
n 
of
 T
-b
et
, I
L-
6,
 2
2,
 1
2a
. 
In
cr
ea
se
d 
ex
pr
es
si
on
 o
f 
TR
E
M
2 
an
d 
D
A
P
2 
in
 w
hi
te
 
an
d 
gr
ay
 m
at
te
r 
(in
na
te
 
im
m
un
e 
re
sp
on
se
)
N
ot
 re
po
rt
ed
S
ev
en
ty
 m
in
ut
es
 o
f H
I 
pr
od
uc
ed
 w
hi
te
 a
nd
 g
ra
y 
m
at
te
r 
in
ju
ry
 re
se
m
bl
in
g 
pr
et
er
m
 b
ra
in
 in
ju
ry
. I
nn
at
e 
an
d 
ad
ap
tiv
e 
im
m
un
e 
re
sp
on
se
s 
ar
e 
in
vo
lv
ed
, w
ith
 s
tr
on
g 
bi
as
 to
 T
h1
/T
h1
7.
 T
R
E
M
2 
an
d 
D
A
P
2 
ar
e 
im
pl
ic
at
ed
 in
 
ol
ig
od
en
dr
oc
yt
e 
pa
th
ol
og
y
a Is
ch
em
ia
 m
od
el
s 
re
fe
r 
to
 s
om
e 
bi
la
te
ra
l c
ar
ot
id
 a
rt
er
y 
oc
cl
us
io
n 
(B
C
A
O
) m
od
el
s 
th
at
 d
id
 n
ot
 u
se
 h
yp
ox
ic
 c
on
di
tio
ns
 fo
llo
w
in
g 
ar
te
ry
 li
ga
tio
n/
cu
t. 
A
na
ly
ze
d 
he
re
 fo
r 
th
e 
pu
rp
os
e 
of
 c
om
pa
ris
on
 a
s 
cl
os
el
y 
re
la
te
d 
m
od
el
s.
10
Rumajogee et al. Rodent HI and Cerebral Palsy
Frontiers in Neurology | www.frontiersin.org April 2016 | Volume 7 | Article 57
TA
B
Le
 3
 | 
C
o
nt
in
ue
d
have failed to reproduce this model and the contradictory data 
warrant further investigation.
Also in 1999, another BCAO model was developed, which 
studied the effect of temporary bilateral ligation of common 
carotid arteries at PND7 in rats (143). Ligation was carried 
out for 10 min during which rat pups were kept in 8% oxygen. 
Progressive loss of O4 marked OLs was observed 24 h after injury. 
The report is very short and no other data were available, but 
this BCAO model is likely to produce more severe brain damage 
than the BCAO model by Uehara, since hypoxic conditions were 
added to the ischemic injury.
A study by Follett and colleagues also attempted to generate 
a reliable model of white matter injury (96). Parameters of the 
insult were changed in order to produce less severe brain damage: 
instead of 8% oxygen and 3.5 h of hypoxia at +37°C used in the 
Rice–Vannucci model, unilateral carotid artery occlusion was 
followed by 6% oxygen for 1 h at +33–34°C. Mild hypothermia 
during hypoxia has been shown to significantly reduce brain 
damage in rat pups when operated on at PND7 (150), and this 
was confirmed here. Selective mild white matter damage was seen 
24–96 h after the HI procedure, as demonstrated by MBP expres-
sion loss and exclusive white matter ISEL (in situ end labeling) 
staining. The authors found that OL death was associated with 
activation of glutamate AMPA receptors, and vulnerability to 
AMPA activation was maximal at PND7 as compared to PND4 
and PND11. At PND7, the number of AMPA receptors on OLs 
(most at the immature stage of development, O1+ marked) is 
significantly greater than that at PND4 [when pre-OLs (O4+/
O1−) predominate], or at PND11 (mature cells, MBP-positive). 
Administration of the AMPA blocker NBQX prevented brain 
damage in animals at PND7, but not at PND4 and PND11. In 
humans, increased numbers of AMPA receptors were also found 
in pre-OLs and immature OLs between 24 and 32  weeks of 
gestation, and the mechanisms of glutamate-mediated cell death 
look similar (151, 152). Recent studies in rodents (153) have 
confirmed an important role for AMPA receptors that are located 
on pre-OLs and mediate their death, as opposed to immature OLs 
found in the study of Follett and colleagues (96). Hence, this study 
was important since suggested an additional possible pathophysi-
ological mechanism for the HI-related injury and illustrated a 
specific vulnerability of immature OLs (O4+/O1+) compared to 
the younger (O4+/O1) and older OL cells (MBP+). However, this 
study is not without flaws and further validation of this model is 
required.
To study possible interactions between HI and infection/
inflammation during the perinatal period, a new rodent model 
was introduced in 2001 (84). A single dose of LPS was given to 
7-day-old rat pups 4  h before unilateral occlusion which was 
implemented as previously described (93). The combination of 
LPS with HI induced a more severe brain injury compared to HI 
alone. For instance, areas of infarction were enlarged, and there 
were increased concentrations of astrocytes and microglia around 
infarction zones. Mechanisms of immune system involvement in 
tissue damage were explored, and alterations in TLRs, and CD14 
protein concentrations were found. Further research is needed 
to elucidate the pathways of interaction of pathophysiological 
processes.
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In subsequent years, two further models of BCAO were 
reported, in addition to the models of Uehara (PND5) and 
Jelinski (PND7). In the first model (144), surgery was performed 
in rat pups at PND1, and no hypoxia conditions were applied. 
Mild diffuse injury was similar to that seen in human infants with 
PVL. More specifically, the injury was restricted to white matter 
and characterized by decreased numbers of immature and mature 
OLs, and activation of macrophages and microglia (144). In the 
second new model, surgery was undertaken in rats at PND4, and, 
in addition to bilateral arterial occlusion, rats were exposed to 
10–15  min of 8% oxygen hypoxic conditions. Severe gray and 
white matter damage occurred with necrotic areas, loss of mature 
OLs and thinning of the corpus callosum (146).
The three models of BCAO described above produced mild 
and severe brain damage, with selectively affected white matter 
or gray matter. The only BCAO model undertaken in PND1 rats 
(144) produced a selective diffuse white matter injury similar to 
that seen in most PVL cases. The extent of the damage may be 
related to the younger age, different anesthesia agent used, or to 
the method of artery occlusion. Anesthesia duration may affect 
the degree of the injury (154), which is not specified in the study 
reports.
In 2002, Back et  al. published data demonstrating that late 
OL progenitors (O4+/O1−) are selectively vulnerable to HI (56), 
similar to late OL progenitors in human infants at 24–32 weeks 
of gestation (44). Those OL progenitors were found to predomi-
nate at PND 2 (56–58). At PND7, immature OLs comprise 92% 
of all OL cells in the corpus callosum and are significantly less 
sensitive to HI compared to late OL progenitors (56). These 
findings gave rise to subsequent work using rats and mice less 
than 1 week old.
HI performed in rat pups at PND3 with subsequent hypoxia 
for 10  min produced a mild injury of cortical areas, thalamus 
and basal ganglia, necrotic and apoptotic cells, and astrogliosis. 
However, white matter damage was not quantified (145). The 
authors were successful in producing consistent mild brain dam-
age due to preserving HI parameters: duration of surgery was 
kept within 10 min, subsequent hypoxia performed with 6–7% 
oxygen, +35–37°C, and 98–100% humidity.
When the surgery was done at PND3 with subsequent 
hypoxia using 8% oxygen for 60  min, mild white and gray 
matter damage was observed (147). For the first time, gender 
differences in HI-associated pathophysiological processes 
were described: post-hypoxia injections of 2-iminobiotin 
(2-IB) prevented brain damage in females only by suppress-
ing release of cytochrome c from mitochondria. Results 
indicated that HI-induced cell death is mediated by the 
caspase-3 pathway in females, but not in males. This study 
reported a high degree of consistency in their results likely 
due to keeping the duration of isoflurane-maintained surgery 
constant (154).
A mouse model that employed HI performed at PND5 was 
developed recently (148). Different durations of hypoxia were 
investigated, and 70 min of hypoxia was found to induce a pattern 
of diffuse white (MBP staining) and focal gray (MAP2) matter 
injury similar to that in preterm infants with PVL. Innate and 
adaptive immune responses were recorded, and implicated in 
the induction of white matter damage. While MBP staining is 
not sufficient alone to replicate human pathology, it can indicate 
pathology of mature OLs and partially reveal the pathological 
mechanisms.
ADvANCeMeNTS iN CLiNiCAL 
MANAGeMeNT OF PeRiNATAL 
COMPLiCATiONS iN HUMAN iNFANTS 
BASeD ON RODeNT Hi MODeL 
ReSeARCH
Rigorous research using HI models during the last decades have 
elucidated mechanisms of prenatal white and gray matter injury, 
and enabled the development of clinical recommendations to 
diminish injury consequences in premature infants. Avoidance of 
factors implicated in damage occurrence has led to introduction 
of following clinical approaches.
Maintenance of infant Cerebral Perfusion
Maintenance of infant cerebral perfusion was found to be impor-
tant based on studies done using the rodent HI model (101, 
155), and significant effort has been put into the development of 
methods to detect infants with impaired cerebrovascular regula-
tion. Significant decrease in cerebral blood flow during the first 
12 h of life, as detected by near-infrared spectroscopy (NIRS) and 
color Doppler ultrasonography (cD-USG), correlates with poor 
neurological outcome or death (156, 157). Consequently, an array 
of critical care methods aimed at hypotension management has 
been developed (158). Prior to birth, use of magnesium sulfate, 
which, in addition to its vasodilation properties, has antioxidant 
and anticytokine effects, was found to be beneficial in prevent-
ing brain injury and is currently used in clinical practice (135, 
159–162).
Post-injury (PND7) Hypothermia
Post-injury (PND7) hypothermia (+31–34°C) in the HI model 
was found to reduce brain damage to the cortex (150), including 
hippocampus, thalamus, and basal ganglia (120), with improve-
ment evident at PND42 (163). Similar results were found in 
fetal sheep (164) and newborn piglets (165), which have greater 
similarities to human brain maturation rates and structures than 
rodents (149, 166). Therapeutic hypothermia is now the standard 
of care for brain injury control in term infants with perinatal 
hypoxic–ischemic encephalopathy (167, 168); however, it is not 
yet recommended for preterm infants.
Prevention of Pre-OL Death
Prevention of pre-OL death (92) and maturation arrest are of 
greatest value. Activation of glutamate NMDA (74, 169) and 
AMPA (96) receptors is associated with OL death in HI However, 
no clinical trials investigating the use of glutamate antagonists 
have been commenced. Activation of another glutamate receptor 
type, the mGluR, which is developmentally regulated and is maxi-
mally expressed on the most vulnerable pre-OLs (170), was found 
to counteract oxidative stress and protect OLs (171). Others have 
investigated the role of the constituents of natural health products, 
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and sulforaphane, as potential therapies to reducing the effects of 
oxidative stress and inflammation, in the prevention of CP (172). 
These promising findings are still awaiting translation to clinic.
Measures to address infection/inflammation prevention, 
identification, and management during pregnancy have also 
been considered (173). Despite the fact that the link between 
gestational inflammation and brain damage was not confirmed 
in several studies (80, 81), at present the standard of care in the US 
involves the administration of broad spectrum antibiotics when 
chorioamnionitis is diagnosed (174).
DiSCUSSiON: LiMiTATiONS OF RODeNT 
Hi MODeLS AND THeiR CLiNiCAL 
APPLiCABiLiTY
The focus of the present paper is on rodent HI models since 
rodents are the most cost-effective and the most used species in 
laboratory research. Furthermore, availability of antibodies and 
transgenic animals allows comprehensive exploration of many 
physiological mechanisms. However, considerable limitations 
of rodent models restrict their use, and the present review is 
intended to reveal gaps in the accumulated knowledge and to 
lessen redundancies in ongoing research.
Differences in Brain Organization and the 
Time Line of Brain Maturation in Rodents 
and Humans
Research undertaken in the HI rodent models during the last 
decades has found many similarities between the mechanisms of 
brain injury and damage evolution in rodents and human infants 
with CP. Fine-tuned HI models successfully reproduce hypoxic–
ischemic conditions, the apoptotic–necrotic pattern of white and 
gray matter damage, and neuromotor impairments. However, 
the greatest limitation of the HI rodent models is the difference 
between rodents and humans in the overall complexity of brain 
organization, and the discrepancies in the rate of maturation in 
any time period (149).
Hypoxia–ischemia rodent models can be used to induce brain 
injury at a similar stage of cellular development: between 24 and 
32 weeks of gestation in human, and at PND2-3 in rodents. Most 
of the oligodendroglial lineage cells are at the stage of pre-OLs at 
these time points, and these are maximally vulnerable to hypoxic–
ischemic injury (Table  1). However, despite the existence of a 
similar cellular stage of development, the speed and duration of 
structural maturation of the developing brain is significantly dif-
ferent in rodents and humans. There is a huge difference between 
the size of a human and a rodent brain and, in particular, the 
cerebral cortex, which is associated with considerably longer 
neurogenesis in humans (175, 176). Accordingly, the structure 
and relative size of the subplate, which is the major target of 
hypoxic–ischemic injury, is different in humans and rodents. In 
humans, the subplate is a more dynamic structure, is more com-
plex and compartmentalized, and is involved to a greater extent in 
the formation of the cortex pathways than in rodents (177, 178). 
In rodents, the subplate is a complete structure by E16–18 (179), 
while in humans it reaches its maximal thickness considerably 
later, at 24–32 weeks of gestation (37). Moreover, the increased 
complexity of the human subplate may contribute to differential 
vulnerability in response to HI in rodents and humans (180).
In an optimized HI rodent model, injury is induced at PND2–3, 
to match the developmental stage of the OLs to that in humans 
(24–32 weeks of gestation) (55–57, 96). Moreover, striking simi-
larities between reduced cortical activity following HI and sub-
sequent brain development both in infants and in rodents have 
been found (33). However, the state of subplate development is 
different at these time points: at PND2–3 in rodents, the subplate 
is already losing cells and function (181), whereas in humans at 
24–32 weeks of gestation the subplate is at its maximal thickness 
and is actively participating in corticogenesis (37). Therefore, the 
consequences of subplate damage will be significantly different 
between humans and rodents, which indicates the limited clinical 
relevance of this HI rodent model (180).
Sex Differences in Response to Prenatal 
injury
Another important limitation of HI models concerns sex differ-
ences relating to brain vulnerability and the ability to repair in 
humans and rodents. In low weight infant boys, the incidence of 
intraventricular hemorrhage is significantly higher (182), as is the 
incidence of spastic CP, compared to girls (by 20–30%) (183–186). 
Moreover, the recovery of brain volumes is lower in boys than 
in girls: low weight preterm boys still present with white matter 
deficits at the age of 8, while matched-weight girls do not (187).
In the rodent model, sex differences in the pathophysiological 
mechanisms underlying brain damage evolution and recovery 
were observed. In females, caspase-dependent apoptosis has been 
described (147, 188), while in males, cell death and subsequent 
brain damage is associated with a different pathway involving 
PARP activation (189). Hypothermia following HI injury was 
beneficial for females only (163); however, the finding of sex 
differences was not a primary aim of the study, and the results, 
therefore, require additional verification, as acknowledged by 
the authors. Despite the different sex physiological processes in 
response to injury, the final extent of brain damage following HI 
at PND7 (190, 191) or before puberty (192), was similar in males 
and females. However, the above studies were done in PND7 
and older animals, when development of a rodent brain roughly 
corresponds to a term human infant. Delivery of acute HI injury 
at PND3 (193) or chronic HI between PND3 and PND11 (194) 
induced significantly greater damage of white and gray matter, 
greater reduction in brain volume and more cognitive deficits 
in males compared to females, thereby resembling the damage 
pattern observed in preterm infants.
In rodents and humans, sex-specific responses to hypoxic–
ischemic injury are different, making the rodent model a 
non-ideal choice to study gender-dependent mechanisms of CP. 
However, sex-specific influences are complex, and the contradic-
tory evidence (193, 194) warrants further research to elucidate 
sex-specific mechanisms of HI-response maturation.
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Modeling Motor impairments
Spastic CP is characterized by aberrant reflex development and 
the lack of voluntary control (8). Unilateral damage of the CST 
during the prenatal period, when motor networks are at the stage 
of refinement – strengthening useful and eliminating redundant 
connections – results in ipsilateral aberrant CST projections and 
abnormal reflexes that manifest in spasticity (195, 196).
Considerable data have been accumulated regarding motor 
impairments in the rodent HI model. Despite rodents not show-
ing the severe spastic impairments observed in human patients, 
gross motor function impairments could be said to resemble 
those in hemi- or diplegic CP (146, 190, 197–200). Most studies 
were undertaken within a week of the insult, and a relatively 
small number of papers have addressed the correlation between 
specific lesions and motor performance in the long term (2). 
Impairments in fine skilled voluntary movement following HI 
are studied even more rarely (198), even though they are present 
in most cases of spastic CP due to corticospinal pathway damage 
(201–204).
There are several concerns regarding the modeling of CST 
injury in rodent HI models. First, the overall anatomy of the CST 
differs considerably from that in humans. Rodents have very few 
direct connections between the motor cortex and motor neurons 
in the ventral horn of the spinal cord (205, 206), specifically for 
motor neurons innervating the muscles of the fingers. Therefore, 
impairments of skilled voluntary movements may be less pro-
nounced in rodents, and require sensitive behavioral tests for 
identification.
Another important anatomical difference is the number of 
axons within the CST, which decussate in the medulla to the 
contralateral side. In rodents 2–4% axons remain uncrossed 
(207), whereas in humans about 8–15% of axons stay at the 
ipsilateral side (195). In humans, there is an even greater amount 
of ipsilateral axons within the CST in the prenatal period when 
injury occurs. These form transient connections with spinal 
cord neurons and disappear during postnatal development due 
to the functional competition with contralateral projections. 
In patients with hemiplegia, those ipsilateral connections are 
preserved and contribute to spastic symptoms (196, 208, 209). In 
rodents, research suggests that the mostly contralateral pattern 
of innervation is determined from the onset with no transient 
ipsilateral projections comparable to those in humans (210, 211). 
However, in rodents, if brain lesions are induced in the first week 
after birth, when the majority of corticospinal fibers are growing 
into the spinal cord, considerably enlarged ipsilateral connections 
are formed that might resemble the aberrant ipsilateral CST 
projections observed in CP patients (212, 213). Indeed, mice 
demonstrated mirror voluntary bilateral synchronous move-
ments following CST injury at PND0-3 that resembled mirror 
movements in CP patients (214).
In addition to governing voluntary fine movements of the 
forelimb, the CST plays an important role in the fine-tuning of 
spinal reflexes during spinal networks maturation, both in rodents 
(215, 216) and humans (211, 217, 218). However, the extent of 
that influence is likely different in rodents and humans, as evi-
denced by the effect of prenatal CST damage. More specifically, 
in humans this type of damage is associated with aberrant reflexes 
and disabling spasticity, while in rodents the effect is considerably 
weaker.
In summary, the anatomy of the CST is considerably different 
in rodents and humans, which limits clinical applicability of HI 
models. However, there is still a possibility of mimicking and 
studying specific processes involved in functional alteration and 
restoration, which may contribute to the development of treat-
ment strategies in humans. For example, finding the crucial role 
of CST influence on fine-tuning of spinal modules during their 
maturation suggests that CP infants would benefit from boost-
ing activity in the residual corticospinal innervation that might 
restore spinal connectivity pattern and reduce spasticity in future 
(211). In the rodent model, stimulating the HI-injured hemisphere 
will have an overall similar effect, though less pronounced in the 
ipsilateral side, due to less CST ipsilateral connections in rodents 
compared to humans.
The Rodent Model versus Large Animal 
Models
The rodent HI model is the most convenient, cost-effective, and 
widely used animal model and has yielded a substantial body of 
knowledge on CP pathophysiology. However, limitations of the 
rodent HI model have prompted research in large animal spe-
cies with greater similarity to humans. The fetal instrumented 
sheep model has been characterized: preterm fetal fetus (95 days 
of gestation, equivalent to 24–28 gestational weeks in humans) 
was found to display cerebral hemodynamics similar to that in 
the human fetus, both in normal conditions (219, 220) and in 
response to HI (221, 222). Moreover, the gyrencephalic structure 
of the sheep brain cerebrum and the major stages of neurodevel-
opment are similar to those in humans (223–225). In addition, 
the larger size of sheep allows chronic monitoring of the fetus 
and relevant clinical interventions have been developed based on 
that model (164). The major disadvantage of the instrumented 
fetal sheep model is the lack of opportunity to study motor 
deficiencies, especially dexterity movements, associated with 
hypoxic–ischemic insult (226).
A non-human primate model developed in baboons at 
125  days of gestation, equivalent to 26  weeks of gestation in 
human, has shown similarities with human preterm infants in 
the pattern of white matter injury (227). The primate model is 
associated with the necessity for artificial ventilation (228) that 
may resemble a specific human condition, though overall it may 
restrict the interpretation and applicability of the results.
A HI model in a newborn piglet has demonstrated electro-
physiological and neuropathological disturbances similar to 
those in the asphyxiated term human infant (229). The model 
is able to mimic comparable changes in brain white matter to a 
human newborn (230). However, high mortality and discrepan-
cies in protocols result in variability in the extent of brain injury 
and make it difficult to draw firm conclusions.
intra- versus extra-Uterine Models
Differences in the rate of brain maturation between rodents and 
humans prevent concomitant times when both structural and 
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cellular components are at the same level of development. Thus, 
in intra-uterine studies in rodents (E17–19), injury is induced 
when the brain subplate is already a complete structure (179). This 
period corresponds to 24–32 gestational weeks in humans when 
the subplate reaches its maximal thickness (37) and synaptogen-
esis begins both in rodents (231, 232) and in humans (233, 234). 
While at this stage the level of subplate development is comparable 
in both rodents and humans, the subsequent differentiation and 
function of the subplate in humans is considerably different from 
that in rodents (180). Moreover, maximal population of pre-OLs 
in rodents is found between PND2 and PND5, while in humans 
the peak of subplate development is between 23 and 32 weeks of 
gestation that coincides with the period of highest vulnerability 
to perinatal brain injury (32).
By contrast, extra-uterine HI models aim to induce brain 
injury during maximal OL vulnerability, for example, between 
PND2 and PND5 in rodents. Therefore, intra-uterine rodent 
models target different aspects of brain pathophysiology associ-
ated with HI (65). Intra-uterine growth restriction models are 
being developed in guinea pigs (235–237), mice (238), rabbits 
(239), and rats (67, 172, 240, 241).
The instrumented fetal sheep model makes it possible to 
induce hypoxic–ischemic injury at the stage of both the subplate 
and pre-OLs being at the similar stages of development in sheep 
and humans and, therefore, more closely mimics events accom-
panying hypoxic–ischemic insult (226).
CONCLUSiON
The rodent HI model continues to contribute to CP research. 
It mimics many pathophysiological changes in human patients 
with spastic CP and allows the study of the mechanisms under-
lying pre- or perinatal brain injury. Unilateral injury induced at 
PND3-4 in combination with precisely adjusted temperature and 
oxygen level and surgery duration can reproduce brain damage 
patterns and motor impairments similar to those in hemiplegic 
CP patients. Moreover, the model allows investigation of new 
methods of brain damage prevention and repair both at the 
cellular (introduction of pharmacological or biotechnological 
agents interrupting the cascade of pathophysiological events) 
and the systemic level (stem cell transplantation or behav-
ioral manipulations stimulating anatomical and functional 
restoration).
Research done using the HI rodent model has identified fac-
tors implicated in brain pathophysiology, and has made impor-
tant contributions to the current clinical practice of treating CP 
patients. For instance, postnatal hypothermia, management of 
decreased cerebral blood flow in newborns, and management 
of prenatal infection are common standards of care in many 
countries at present. However, the model has important limita-
tions, such as overall anatomical differences between human and 
rodent brains, discrepancies in the rate of maturation at any time 
period, and in gender-specific mechanisms. These limitations 
restrict the clinical applicability of the results. The rodent model 
is an ideal cost-effective model for proof-of-concept studies and 
investigation of molecular mechanisms that can be validated 
subsequently in large pre-clinical animal models, such as the 
instrumented fetal sheep (226), and the monkey model that, in 
addition to physiological and size similarities, allows evaluation 
of functional outcomes.
MeTHOD
The goal of the present study was to identify HI rodent models 
developed to date, analyze their contributions to the understand-
ing of CP pathophysiological mechanisms, and to comment on 
the overall potential of the HI rodent model to mimic those 
mechanisms. A systematic literature search was conducted in 
May–July 2015 using PubMed, Scopus, Medline, Cochrane 
Library, and Web of Science databases in English. The following 
search strategies were used.
PubMed (All Years)
Title/Abstract (“hypoxia ischemia” OR “hypoxic ischemic” OR 
“BCAO”) AND Title/Abstract (“rat” OR “rats” OR “mice” OR 
“mouse”) AND Title/Abstract (“cerebral palsy” OR “white mat-
ter” OR “injury”) returned 1434 results.
Scopus
Title, abstract, keywords (“hypoxia ischemia” OR “hypoxic 
ischemic” OR BCAO) AND Title, abstract, keywords (“rat?” OR 
“mice” OR “mouse”) AND Title, abstract, keywords (“cerebral 
palsy” OR “white matter” OR “injury”) returned 1364 results.
Medline (OviD MedLine without Revisions, 
1996 – July week 2, 2015)
Title/Abstract (“hypoxia ischemia” OR “hypoxic ischemic”) AND 
Title/Abstact (“rat” OR “rats” OR “mice” OR “mouse”) AND 
Title/Abstact (“cerebral palsy” OR “white matter” OR “injury”) 
returned 1554 results.
Cochrane Library (All Databases,  
All Years)
Title, abstract, keywords (“hypoxia ischemia” OR “hypoxic 
ischemic” OR BCAO) AND (rat OR rats OR mice OR mouse) 
AND (“cerebral palsy” OR “white matter” OR injury) returned 
3 results.
web of Science (without Restrictions,  
All Years)
Title: (“hypoxia ischemia” OR “hypoxic ischemic” OR BCAO) 
AND Topic: (rat OR rats OR mice OR mouse) AND Topic: 
(“cerebral palsy” OR “white matter” OR injury) returned 1341 
results.
Titles and abstracts of found papers were screened to determine 
if they fell into the scope of the review. From the selected papers, 
only those which satisfied the following criteria were analyzed.
Criteria for Paper inclusion into Analysis
The following papers were included: papers that were relevant to 
the subject, clearly described methods of research, had control 
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groups, used appropriate outcome measures in which subjects are 
randomized and data scoring were blinded, and that report limi-
tations of the research conducted. A total of 11 distinct rodent HI 
and two ischemic models (Table 3) were identified and analyzed 
in our review.
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